A molecular signature of metastasis in primary solid tumors (original) (raw)

• Hellman, S., DeVita, V.T. & Rosenberg, S.A. Cancer: principles & practice of oncology. (Lippincott-Raven, Philadelphia, 2001).
  Google Scholar
• Poste, G. & Fidler, I.J. The pathogenesis of cancer metastasis. Nature 283, 139–146 (1980).
  Article CAS PubMed Google Scholar
• Fidler, I.J. & Kripke, M.L. Metastasis results from pre-existing variant cells within a malignant tumor. Science 197, 893–895 (1977).
  Article CAS PubMed Google Scholar
• Clark, E.A., Golub, T.R., Lander, E.S. & Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535 (2000).
  Article CAS PubMed Google Scholar
• Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98, 13790–13795 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Schiller, J.H. et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N. Engl. J. Med. 346, 92–98 (2002).
  Article CAS PubMed Google Scholar
• van't Veer, L.J. et al. Gene-expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002).
  Article CAS Google Scholar
• Singh, D. et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203–209 (2002).
  Article CAS PubMed Google Scholar
• Pomeroy, S.L. et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436–442 (2002).
  Article CAS PubMed Google Scholar
• Shipp, M.A. et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8, 68–74 (2002).
  Article CAS PubMed Google Scholar
• Anand, N. et al. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet. 31, 301–305 (2002).
  Article CAS PubMed Google Scholar
• Zou, H., McGarry, T.J., Bernal, T. & Kirschner, M.W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285, 418–422 (1999).
  Article CAS PubMed Google Scholar
• Jallepalli, P.V. et al. Securin is required for chromosomal stability in human cells. Cell 105, 445–457 (2001).
  Article CAS PubMed Google Scholar
• Heaney, A.P. et al. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355, 716–719 (2000).
  Article CAS PubMed Google Scholar
• Bernal, J.A. et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat. Genet. 32, 306–311 (2002).
  Article CAS PubMed Google Scholar
• Skobe, M. & Fusenig, N.E. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl. Acad. Sci. USA 95, 1050–1055 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Olumi, A.F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999).
  CAS PubMed Google Scholar
• Brown, L.F. et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res. 5, 1041–1056 (1999).
  CAS PubMed Google Scholar
• Jensen, B.V., Johansen, J.S., Skovsgaard, T., Brandt, J. & Teisner, B. Extracellular matrix building marked by the N-terminal propeptide of procollagen type I reflect aggressiveness of recurrent breast cancer. Int. J. Cancer 98, 582–589 (2002).
  Article CAS PubMed Google Scholar
• Pardoll, D.M. Spinning molecular immunology into successful immunotherapy. Nat. Rev. Immunol. 2, 227–238 (2002).
  Article CAS PubMed Google Scholar
• Song, W.J. et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23, 166–175 (1999).
  Article CAS PubMed Google Scholar
• Bernards, R. & Weinberg, R.A. Metastasis genes: a progression puzzle. Nature 418, 823 (2002).
• Braun, S. et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N. Engl. J. Med. 342, 525–533 (2000).
  Article CAS PubMed Google Scholar
• Hainsworth, J.D. & Greco, F.A. Treatment of patients with cancer of an unknown primary site. N. Engl. J. Med. 329, 257–263 (1993).
  Article CAS PubMed Google Scholar
• Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).
  Article CAS PubMed Google Scholar
• Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene-expression profiling. Nature 403, 503–511 (2000).
  Article CAS PubMed Google Scholar
• Ramaswamy, S. et al. Multiclass cancer diagnosis using tumor gene-expression signatures. Proc. Natl. Acad. Sci. USA 98, 15149–15154 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Golub, T.R. et al. Molecular classification of cancer: class discovery and class prediction by gene-expression monitoring. Science 286, 531–537 (1999).
  Article CAS PubMed Google Scholar
• Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863–14868 (1998).
  Article CAS PubMed PubMed Central Google Scholar